The bill amends Section 3 of Act No. 324 from the 2023 Regular Session of the Louisiana Legislature, specifically addressing the implementation of biomarker testing provisions. The previous requirement for the provisions to become effective only upon a specific appropriation of funds has been removed. Instead, the bill establishes that the Act will take effect upon the governor's signature or, if not signed, after the designated time for bills to become law without a signature. If the governor vetoes the bill but it is later approved by the legislature, the Act will take effect the day after that approval.

Additionally, the bill clarifies that its provisions will apply to any new policy, contract, program, or health coverage plan issued on or after January 1, 2025. This change aims to streamline the implementation process for biomarker testing and ensure that the relevant health coverage is available in a timely manner.